GT Biopharma

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell GT Biopharma and other ETFs, options, and stocks.

About GTBP

GT Biopharma, Inc. is a clinical stage biopharmaceutical company focused on the development and commercialization of the immuno-oncology therapeutic products based proprietary TriKE NK cell engager platform. The TriKE platform is designed to harness and enhance the cancer killing abilities of a patient's immune system natural killer cells (NK cells). 

CEO
Michael Breen
CEOMichael Breen
Employees
1
Employees1
Headquarters
San Francisco, California
HeadquartersSan Francisco, California
Founded
1965
Founded1965
Employees
1
Employees1

GTBP Key Statistics

Market cap
10.84M
Market cap10.84M
Price-Earnings ratio
-0.02
Price-Earnings ratio-0.02
Dividend yield
Dividend yield
Average volume
716.83K
Average volume716.83K
High today
$0.3539
High today$0.3539
Low today
$0.3152
Low today$0.3152
Open price
$0.3265
Open price$0.3265
Volume
1.08M
Volume1.08M
52 Week high
$3.85
52 Week high$3.85
52 Week low
$0.261
52 Week low$0.261

Stock Snapshot

GT Biopharma(GTBP) stock is priced at $0.34, giving the company a market capitalization of 10.84M. It carries a P/E multiple of -0.02.

As of 2026-05-02, GT Biopharma(GTBP) stock has fluctuated between $0.32 and $0.35. The current price stands at $0.34, placing the stock +7.9% above today's low and -3.9% off the high.

GT Biopharma(GTBP) shares are trading with a volume of 1.08M, against a daily average of 716.83K.

During the past year, GT Biopharma(GTBP) stock moved between $0.26 at its lowest and $3.85 at its peak.

During the past year, GT Biopharma(GTBP) stock moved between $0.26 at its lowest and $3.85 at its peak.

People also own

Based on the portfolios of people who own GTBP. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.